May 24 & May 25, 2022
16:00 – 18:30 CEST
10:00 AM – 12:30 PM EDT

Faecal microbiota transplantation (FMT) is widely reported to be an effective treatment against recurrent Clostridium difficile infections. Recent clinical evidence supports the therapeutic use of FMT for a wide range of pathologies including inflammatory bowel disease, oncology, obesity, and other functional or metabolic disorders. This IABS sponsored webinar aims to provide a multi-disciplinary perspective of ongoing efforts to understand the potential of FMT to treat clinical disorders. These include evaluation of safety, efficacy, clinical trial design, and the potential for standardization across these areas. Speakers will review recent scientific advances for the technical, regulatory, and standardization efforts surrounding FMT. Recognized experts will give insights into state-of-the art approaches and methods developed by international organizations and institutions.